Please assess the completion status of the following clinical trial:

Trial Title: Antipsychotic Induced Structural and Functional Brain Changes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with diagnosis of schizophrenia according to DSM-5~* Age 18-65 years~* Written declaration of consent~* Subjects being contractually and mentally capable to attend the medical staffs' orders.~* MRI capability~Exclusion Criteria:~* Relevant somatic diseases, which could have an impact on the conduct of the study based on clinical judgement of the treating physician (e.g. epilepsy, cancer)~* Prior insufficiently documented drug therapy with antipsychotics~* Magnetic metals in and on the body, cardiac pacemakers and body piercings.~* Pregnancy or lactation~* Hospitalization of the patient ordered by the court or public authorities~* Relationship of dependence or employment to sponsor or investigator~* Simultaneous participation in another clinical trial (participation in an APIC subproject excluded)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Maintenance treatment (Control) (Type: ACTIVE_COMPARATOR): 287 female and male patients with schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders-V (DSM-V) will be directed randomly to the maintenance treatment group (control). Patients will be treated according to the current clinical standard of long-term maintenance antipsychotic treatment. Study related procedures include safety assessments (physical examination, questionaires), laboratory assessments (blood sampling, urine analysis), efficacy assessments (questionaires) and volumetric Magnetic Resonance Imaging (structural MRI incl. volumetry). Study procedures are the same for both study groups (control/experimental).
- Intermittent Treatment (Experimental) (Type: EXPERIMENTAL): 287 female and male patients with schizophrenia according to DSM-V will be directed randomly to the intermittent treatment group (experimental). Patients directed to this group will be tapered off medication.~Study related procedures include safety assessments (physical examination, questionaires), laboratory assessments (blood sampling, urine analysis), efficacy assessments (questionaires) and volumetric Magnetic Resonance Imaging (structural MRI incl. volumetry). Study procedures are the same for both study groups (control/experimental).

Based on this trial design, predict the completion outcome and termination type (if applicable).